Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 496 AL 510

Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence

Li X, Wang X, Guo L, Wu K, Wang L, Rao L, Liu X, Kang C, Jiang B, Li Q, Li H, He F, Lu C.

Ageing Res Rev. 2023 Aug;89:101984. doi: 10.1016/j.arr.2023.101984. Epub 2023 Jun 15.

Predicting cognitive decline in older people by structural and molecular imaging

Teipel S, Tang Y, Boccardi M.

Curr Opin Neurol. 2023 Aug 1;36(4):253-263. doi: 10.1097/WCO.0000000000001172. Epub 2023 Jun 19.

Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials

Rahman-Filipiak A, Bolton C, Grill JD, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler NR, Rosen A, Lingler J, Wijsman E, Clark L; Advisory Group on Risk Evidence Education in Dementia (AGREED).

Alzheimers Dement. 2023 Sep;19(9):4270-4275. doi: 10.1002/alz.13380. Epub 2023 Jul 14.

PET Radiomics of White Matter, Can Be Employed as a Biomarker to Identify the Progression of Mild Cognitive Impairment to Alzheimer's Disease

Chen F.

Acad Radiol. 2023 Sep;30(9):1885-1886. doi: 10.1016/j.acra.2023.06.020. Epub 2023 Jul 17.

The performance of plasma phosphorylated tau231 in detecting Alzheimer's disease: A systematic review with meta-analysis

Xu C, Zhao L, Dong C.

Eur J Neurosci. 2023 Aug;58(4):3132-3149. doi: 10.1111/ejn.16085. Epub 2023 Jul 27.

Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis

Fan Z, Liu X, Liu J, Chen C, Zhou M.

J Integr Neurosci. 2023 Jun 30;22(4):85. doi: 10.31083/j.jin2204085.

Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study

van de Sande N, Ramakers IHGB, Visser PJ, Verhey FRJ, Verbraak FD, Bouwman FH, Berendschot TTJM, Nuijts RMMA, Webers CAB, Gijs M.

BMC Neurol. 2023 Aug 5;23(1):293. doi: 10.1186/s12883-023-03335-y.

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study

Hong YJ, Ho S, Jeong JH, Park KH, Kim S, Wang MJ, Choi SH, Yang DW; CoSCo study group.

Alzheimers Res Ther. 2023 Aug 7;15(1):132. doi: 10.1186/s13195-023-01273-y.

Obstructive sleep apnea and dementia: A role to play?

Kinugawa K.

Rev Neurol (Paris). 2023 Oct;179(7):793-803. doi: 10.1016/j.neurol.2023.08.006. Epub 2023 Aug 24.

Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis

Gaur A, Rivet L, Mah E, Bawa KK, Gallagher D, Herrmann N, Lanctôt KL.

Ageing Res Rev. 2023 Nov;91:102046. doi: 10.1016/j.arr.2023.102046. Epub 2023 Aug 28.

Bibliometric review on biomarkers for Alzheimer's disease between 2000 and 2023

Yang X, Qu H.

Medicine (Baltimore). 2023 Sep 8;102(36):e34982. doi: 10.1097/MD.0000000000034982.

Tear Biomarkers and Alzheimer's Disease

Kaštelan S, Braš M, Pjevač N, Bakija I, Tomić Z, Pjevač Keleminić N, Gverović Antunica A.

Int J Mol Sci. 2023 Aug 30;24(17):13429. doi: 10.3390/ijms241713429.

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski EJ, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici GD; LEADS Consortium.

Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S98-S114. doi: 10.1002/alz.13453. Epub 2023 Sep 10.

The potential clinical value of plasma biomarkers in Alzheimer's disease

Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, Carboni M, Jethwa A, Suridjan I, Zetterberg H.

Alzheimers Dement. 2023 Dec;19(12):5805-5816. doi: 10.1002/alz.13455. Epub 2023 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias